Literature DB >> 1709698

Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate-early protein ICP27.

T A Banks1, E M Allen, S Dasgupta, R Sandri-Goldin, B T Rouse.   

Abstract

The identity of herpes simplex virus type 1 (HSV-1) antigens that serve as targets for cytotoxic T lymphocytes (CTL) and their ability to induce protective immunity remain uncertain. In this article, we report the identification of the immediate-early protein ICP27 as a CTL antigen in H-2d mice but not in H-2k or H-2b mice. Calculation of the frequencies of H-2d-restricted virus-specific CTL demonstrated that approximately one-fourth of the total HSV-1-specific response was directed against ICP27. To define the location of this CTL epitope, four truncated derivatives of the ICP27 gene which place the epitope in a 217-amino-acid region (amino acids 189 to 406) near the central portion of the protein were constructed. Mice immunized with ICP27 were able both to induce HSV-1-specific CTL and to survive a lethal intraperitoneal challenge with virulent HSV-1. However, neither appreciable antibody nor delayed-type hypersensitivity responses were induced in immunized mice, and they were also unable to clear a local epithelial virus challenge. It appears that ICP27, although capable of inducing several aspects of the immune response, is by itself unable to provide complete immunity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709698      PMCID: PMC240975     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.

Authors:  R J Murray; L S Young; A Calender; C D Gregory; M Rowe; G M Lenoir; A B Rickinson
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Cytotoxic T lymphocytes. Their relevance in herpesvirus infections.

Authors:  S Martin; E Cantin; B T Rouse
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

3.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

4.  Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0.

Authors:  S Martin; X X Zhu; S J Silverstein; R J Courtney; F Yao; F J Jenkins; B T Rouse
Journal:  J Gen Virol       Date:  1990-10       Impact factor: 3.891

5.  Role of coexpression of IL-2 and herpes simplex virus proteins in recombinant vaccinia virus vectors on levels of induced immunity.

Authors:  E M Allen; J P Weir; S Martin; C Mercadal; B T Rouse
Journal:  Viral Immunol       Date:  1990       Impact factor: 2.257

6.  Specificity of the immune response of mice to herpes simplex virus glycoproteins B and D constitutively expressed on L cell lines.

Authors:  B A Blacklaws; A A Nash; G Darby
Journal:  J Gen Virol       Date:  1987-04       Impact factor: 3.891

7.  Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize virus nonstructural proteins.

Authors:  S Martin; R J Courtney; G Fowler; B T Rouse
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

8.  A recombinant vaccinia virus expressing herpes simplex virus type 1 glycoprotein B induces cytotoxic T lymphocytes in mice.

Authors:  E McLaughlin-Taylor; D E Willey; E M Cantin; R Eberle; B Moss; H Openshaw
Journal:  J Gen Virol       Date:  1988-07       Impact factor: 3.891

9.  Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate-early protein pp89 expressed by recombinant vaccinia virus.

Authors:  H Volkmer; C Bertholet; S Jonjić; R Wittek; U H Koszinowski
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

10.  Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses.

Authors:  L K Borysiewicz; J K Hickling; S Graham; J Sinclair; M P Cranage; G L Smith; J G Sissons
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  12 in total

1.  The reovirus nonstructural protein sigma1NS is recognized by murine cytotoxic T lymphocytes.

Authors:  L M Hoffman; K T Hogan; L W Cashdollar
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

2.  DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector.

Authors:  M J Hariharan; D A Driver; K Townsend; D Brumm; J M Polo; B A Belli; D J Catton; D Hsu; D Mittelstaedt; J E McCormack; L Karavodin; T W Dubensky; S M Chang; T A Banks
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

3.  Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice.

Authors:  T J Smith; C E Ackland-Berglund; D A Leib
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection.

Authors:  L H Nguyen; D M Knipe; R W Finberg
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

5.  Immunization with the immediate-early tegument protein (open reading frame 62) of varicella-zoster virus protects guinea pigs against virus challenge.

Authors:  C Sabella; P W Lowry; G M Abbruzzi; C M Koropchak; P R Kinchington; M Sadegh-Zadeh; J Hay; W T Ruyechan; A M Arvin
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  Development and antigen specificity of the lymphoproliferation responses of pigs to pseudorabies virus: dichotomy between secondary B- and T-cell responses.

Authors:  T G Kimman; T M De Bruin; J J Voermans; B P Peeters; A T Bianchi
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

7.  Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Th1+ T cells.

Authors:  E Manickan; M Francotte; N Kuklin; M Dewerchin; C Molitor; D Gheysen; M Slaoui; B T Rouse
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

Review 8.  Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virus.

Authors:  Michael W Ferenczy
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

9.  Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus.

Authors:  T A Banks; S Nair; B T Rouse
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

10.  Polymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes.

Authors:  L A Salvucci; R H Bonneau; S S Tevethia
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.